Literature DB >> 28159836

c-Myc downregulation is required for preacinar to acinar maturation and pancreatic homeostasis.

Victor J Sánchez-Arévalo Lobo1, Luis César Fernández1, Enrique Carrillo-de-Santa-Pau1, Laia Richart1, Isidoro Cobo1, Jaroslaw Cendrowski1, Ulisses Moreno1, Natalia Del Pozo1, Diego Megías2, Bernardette Bréant3, Christopher V Wright4, Mark Magnuson4, Francisco X Real1,5.   

Abstract

BACKGROUND AND AIMS: c-Myc is highly expressed in pancreatic multipotent progenitor cells (MPC) and in pancreatic cancer. The transition from MPC to unipotent acinar progenitors is associated with c-Myc downregulation; a role for c-Myc in this process, and its possible relationship to a role in cancer, has not been established.
DESIGN: Using coimmunoprecipitation assays, we demonstrate that c-Myc and Ptf1a interact. Using reverse transcriptase qPCR, western blot and immunofluorescence, we show the erosion of the acinar programme. To analyse the genomic distribution of c-Myc and Ptf1a and the global transcriptomic profile, we used ChIP-seq and RNA-seq, respectively; validation was performed with ChIP-qPCR and RT-qPCR. Lineage-tracing experiments were used to follow the effect of c-Myc overexpression in preacinar cells on acinar differentiation.
RESULTS: c-Myc binds and represses the transcriptional activity of Ptf1a. c-Myc overexpression in preacinar cells leads to a massive erosion of differentiation. In adult Ela1-Myc mice: (1) c-Myc binds to Ptf1a, and Tcf3 is downregulated; (2) Ptf1a and c-Myc display partially overlapping chromatin occupancy but do not bind the same E-boxes; (3) at the proximal promoter of genes coding for digestive enzymes, we find reduced PTF1 binding and increased levels of repressive chromatin marks and PRC2 complex components. Lineage tracing of committed acinar precursors reveals that c-Myc overexpression does not restore multipotency but allows the persistence of a preacinar-like cell population. In addition, mutant KRas can lead to c-Myc overexpression and acinar dysregulation.
CONCLUSIONS: c-Myc repression during development is crucial for the maturation of preacinar cells, and c-Myc overexpression can contribute to pancreatic carcinogenesis through the induction of a dedifferentiated state. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  ONCOGENES; PANCREATIC CANCER; PANCREATIC DISEASE; PANCREATIC ENZYMES

Mesh:

Substances:

Year:  2017        PMID: 28159836     DOI: 10.1136/gutjnl-2016-312306

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  11 in total

Review 1.  Signaling Networks That Control Cellular Plasticity in Pancreatic Tumorigenesis, Progression, and Metastasis.

Authors:  Howard C Crawford; Marina Pasca di Magliano; Sulagna Banerjee
Journal:  Gastroenterology       Date:  2019-02-01       Impact factor: 22.682

2.  c-MYC amplification and c-myc protein expression in pancreatic acinar cell carcinomas. New insights into the molecular signature of these rare cancers.

Authors:  Stefano La Rosa; Barbara Bernasconi; Alessandro Vanoli; Amedeo Sciarra; Kenji Notohara; Luca Albarello; Selenia Casnedi; Paola Billo; Lizhi Zhang; Maria Grazia Tibiletti; Fausto Sessa
Journal:  Virchows Arch       Date:  2018-05-02       Impact factor: 4.064

3.  Targeting acquired oncogenic burden in resilient pancreatic cancer: a novel benefit from marine polyphenols.

Authors:  Sheeja Aravindan; Dinesh Babu Somasundaram; Somasundaram T Somasundaram; Mohan Natarajan; Terence S Herman; Natarajan Aravindan
Journal:  Mol Cell Biochem       Date:  2019-07-31       Impact factor: 3.396

4.  BRD7 Promotes Cell Proliferation and Tumor Growth Through Stabilization of c-Myc in Colorectal Cancer.

Authors:  Ran Zhao; Yukun Liu; Chunchun Wu; Mengna Li; Yanmei Wei; Weihong Niu; Jing Yang; Songqing Fan; Yong Xie; Hui Li; Wei Wang; Zhaoyang Zeng; Wei Xiong; Xiaoling Li; Guiyuan Li; Ming Zhou
Journal:  Front Cell Dev Biol       Date:  2021-05-24

5.  RNAMethyPro: a biologically conserved signature of N6-methyladenosine regulators for predicting survival at pan-cancer level.

Authors:  Raju Kandimalla; Feng Gao; Ying Li; Hao Huang; Jia Ke; Xin Deng; Linjie Zhao; Shengtao Zhou; Ajay Goel; Xin Wang
Journal:  NPJ Precis Oncol       Date:  2019-05-01

Review 6.  Molecular Alterations in Pancreatic Cancer: Transfer to the Clinic.

Authors:  Yolanda Rodríguez Gil; Paula Jiménez Sánchez; Raúl Muñoz Velasco; Ana García García; Víctor Javier Sánchez-Arévalo Lobo
Journal:  Int J Mol Sci       Date:  2021-02-19       Impact factor: 5.923

7.  Mithramycin-loaded mPEG-PLGA nanoparticles exert potent antitumor efficacy against pancreatic carcinoma.

Authors:  Xu-Jie Liu; Liang Li; Xiu-Jun Liu; Yi Li; Chun-Yan Zhao; Rui-Qi Wang; Yong-Su Zhen
Journal:  Int J Nanomedicine       Date:  2017-07-24

Review 8.  Plasticity of differentiated cells in wound repair and tumorigenesis, part I: stomach and pancreas.

Authors:  Joseph Burclaff; Jason C Mills
Journal:  Dis Model Mech       Date:  2018-07-23       Impact factor: 5.758

9.  EI24 Suppresses Tumorigenesis in Pancreatic Cancer via Regulating c-Myc.

Authors:  Yi Zang; Lei Zhu; Tong Li; Qi Wang; Juanjuan Li; Yuting Qian; Lumin Wei; Mingping Xie; Wen-Hao Tang; Xu Liu; Ying Zhu; Lifu Wang
Journal:  Gastroenterol Res Pract       Date:  2018-10-02       Impact factor: 2.260

Review 10.  Histo-molecular oncogenesis of pancreatic cancer: From precancerous lesions to invasive ductal adenocarcinoma.

Authors:  Giulio Riva; Antonio Pea; Camilla Pilati; Giulia Fiadone; Rita Teresa Lawlor; Aldo Scarpa; Claudio Luchini
Journal:  World J Gastrointest Oncol       Date:  2018-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.